Abstract Aim The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management
of Patients With Atrial Fibrillation” provides recommendations to guide clinicians in the …

Drug-induced ventricular tachyarrhythmias can be caused by cardiovascular drugs,
noncardiovascular drugs, and even nonprescription agents. They can result in arrhythmic …

Electrical storm is characterised by a state of severe electrical instability that occurs in a rare
combination of circumstances, and may lead to multiple implantable cardioverter defibrillator …

This study tested the hypothesis that concomitant sympathetic and parasympathetic
stimulation (“autonomic conflict”) may act as a trigger for arrhythmias in long QT syndrome …

Background Loperamide is a widely available oral μ-opioid receptor agonist, and
loperamide abuse is increasing by those seeking intoxication. Loperamide has potent QTc …

AIM: The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Background Magnetic resonance imaging (MRI) is increasingly becoming the imaging
modality of choice for many clinical disorders due to superior image quality and absence of …

In several case reports a prolongation of the QT-interval and even proarrhythmic effects of
fluconazole and voriconazole were reported. The aim of the present study was to investigate …

A 53-year-old presented to the emergency department following a fall and was found to
have recurrent episodes of torsades de pointes and pulseless ventricular tachycardia on …

Malignant ventricular arrhythmias (eg torsades de pointes-TdP) are the primary cause of
syncope and premature death in patients with abnormal prolongation of the …